Skip to main content
Equibles

ROYCE & ASSOCIATES LP

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 906304 New York, NY
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$432,732
-$1,080 QoQ
Shares Held
54,024
0.0% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 209 holders
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYCE & ASSOCIATES LP holds $280,034,602 across 30 Biotechnology names. SPRY ranks #28 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 789,745 $55,795,484
2 INVA
Innoviva, Inc.
 1,172,690 $26,631,789
3 AXSM
Axsome Therapeutics, Inc.
 91,041 $22,284,105
4 CRMD
CorMedix Inc.
 2,176,362 $17,084,441
5 BBIO
BridgeBio Pharma, Inc.
 218,487 $16,272,911
6 ALMS
Alumis Inc.
 525,303 $14,782,026
7 HRMY
Harmony Biosciences Holdings, Inc.
 362,464 $13,197,314
8 ZVRA
Zevra Therapeutics, Inc.
 882,658 $12,657,315

All Filings in SPRY

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $432,732 54,024
2026-03-31 $433,812 54,024
2025-12-31 $2,412,144 207,051
2025-06-30 $4,471,894 256,269
2025-03-31 $8,085,996 642,766
2024-12-31 $9,807,417 929,613
2024-09-30 $10,026,097 691,455
2024-06-30 $5,494,907 645,700
2024-03-31 $5,709,914 558,700
2023-12-31 $2,595,876 473,700
2023-09-30 $1,752,786 463,700
2023-06-30 $3,106,790 463,700
2023-03-31 $1,978,389 303,900